RxDoctor Payments Data

Anthony Sayegh, MD

Vascular & Interventional Radiology · Albany, NYNPI 1881056935

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,684 of the $7,593 with a category attached, or 61.7%. 7 manufacturers reported payments, led by Boston Scientific at 51.2% of the total. Reporting peaked in 2024 at $2,601 and has fallen 82.3% since, to $460 in 2025.

$7,593in general payments, 2019–2025

Across 89 payments — averaging $85.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$4K
  • Inari Medical, Inc.$1K
  • Medtronic$1K
  • Terumo Medical Corporation$369
  • Penumbra, Inc.$237
  • Stryker$205
  • plus $22 from 1 others

What the payments were for

  • Consulting fees$3755%
  • Travel & lodging$2,26930%
  • Food & beverage$4,68462%
  • Education$2653%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,593 in reported general payments places this provider in the 75th percentile of 306 vascular & interventional radiology providers in New York.

See all vascular & interventional radiology providers in New York →

Medicare billing

Part B allowed, 2024
$144,404
Medicare patients
1,520
Services billed
3,547

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Albany

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →